{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-166249","form_type":"8-K","ticker":"BTMD","cik":"0001819253","company_name":"biote Corp.","filed_at":"2022-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.483490+00:00","generated_at":"2026-06-25T05:12:56.665578+00:00","sec_items":["1.01","2.01","9.01","3.02","2.03","3.03","4.01","5.01","5.02","5.03","5.05","5.06"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Haymaker Acquisition Corp. III completes merger with Biote, begins trading as biote Corp. (BTMD)","bullets":["Closed Business Combination with HYAC; combined entity now biote Corp., trading BTMD and BTMDW on Nasdaq.","Entered $125M term loan A and $50M revolving credit facility; matures May 2027; SOFR+2.5% or base+1.5%.","30.5M HYAC public shares redeemed pre-closing; ~9.16M Class A shares outstanding; 58.6M Class V voting shares issued.","Tax Receivable Agreement obligates biote Corp. to pay 85% of tax savings from basis increases to Biote members."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-166249","json":"https://secwatch.observer/filing/0001193125-22-166249.json","markdown":"https://secwatch.observer/filing/0001193125-22-166249.md","text":"https://secwatch.observer/filing/0001193125-22-166249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/d342736d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:12:56.665578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29df766228","claim":"Marc Beer was appointed as Executive Chairman at biote Corp..","evidence_excerpt":"Marc Beer was appointed Executive Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"3bc89f46d5","claim":"Marc Beer was appointed as Director at biote Corp..","evidence_excerpt":"Teresa Weber, Andrew Heyer, Steven Heyer, Dana Jacoby, Mark Cone, M.D. and Marc Beer were appointed as directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3f1d72602c","claim":"Dana Jacoby was appointed as Director at biote Corp..","evidence_excerpt":"Teresa Weber, Andrew Heyer, Steven Heyer, Dana Jacoby, Mark Cone, M.D. and Marc Beer were appointed as directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"993c7e9a01","claim":"Steven Heyer was appointed as Director at biote Corp..","evidence_excerpt":"Teresa Weber, Andrew Heyer, Steven Heyer, Dana Jacoby, Mark Cone, M.D. and Marc Beer were appointed as directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ab5dd0d18c","claim":"Teresa Weber was appointed as Director at biote Corp..","evidence_excerpt":"Teresa Weber, Andrew Heyer, Steven Heyer, Dana Jacoby, Mark Cone, M.D. and Marc Beer were appointed as directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"beb5f052eb","claim":"Mark Cone was appointed as Director at biote Corp..","evidence_excerpt":"Teresa Weber, Andrew Heyer, Steven Heyer, Dana Jacoby, Mark Cone, M.D. and Marc Beer were appointed as directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f2d5b35a88","claim":"Andrew Heyer was appointed as Director at biote Corp..","evidence_excerpt":"Teresa Weber, Andrew Heyer, Steven Heyer, Dana Jacoby, Mark Cone, M.D. and Marc Beer were appointed as directors of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312522166249/0001193125-22-166249-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}